So I had seen firsthand how

much time and effort and planning it took to roll out a licanumab treatment for the Mayo Clinic for cognitively impaired individuals.

This effort was led by John Graff Radford, who you'll hear from in a second, and Vijay Ramana.

And it took, John can correct me, but it took, I would say, over a year of very detailed planning that involve many different areas of medicine beyond just the behavioral neurology department.

So pharmacy, fusion clinic, laboratory medicine, neuropsych, and radiology.

And for treatment of unimpaired Alzheimer's disease positive individuals, the scope of the logistics would obviously be much larger, be much more complex.

And this goes beyond the much larger pool of individuals to be screened.

nothing.